BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27458178)

  • 1. The Combination of Periostin Overexpression and Microvascular Invasion Is Related to a Poor Prognosis for Hepatocellular Carcinoma.
    Jang SY; Park SY; Lee HW; Choi YK; Park KG; Yoon GS; Tak WY; Kweon YO; Hur K; Lee WK
    Gut Liver; 2016 Nov; 10(6):948-954. PubMed ID: 27458178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy.
    Lv Y; Wang W; Jia WD; Sun QK; Huang M; Zhou HC; Xia HH; Liu WB; Chen H; Sun SN; Xu GL
    Eur J Surg Oncol; 2013 Oct; 39(10):1129-35. PubMed ID: 23916473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive model for microvascular invasion of hepatocellular carcinoma among candidates for either hepatic resection or liver transplantation.
    Nitta H; Allard MA; Sebagh M; Karam V; Ciacio O; Pittau G; Vibert E; Sa Cunha A; Cherqui D; Castaing D; Bismuth H; Guettier C; Samuel D; Baba H; Adam R
    Surgery; 2019 Jun; 165(6):1168-1175. PubMed ID: 30878140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel prognostic nomogram based on microvascular invasion and hematological biomarkers to predict survival outcome for hepatocellular carcinoma patients.
    Li X; Huang H; Yu X; Chen P; Ouyang J; Huang B
    Surg Oncol; 2020 Jun; 33():51-57. PubMed ID: 32561099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of periostin on hepatocellular carcinoma cells invasion, metastasis and prognosis].
    Wen Q; Shang J; Mise SRL; Bai L
    Zhonghua Gan Zang Bing Za Zhi; 2019 Oct; 27(10):766-771. PubMed ID: 31734990
    [No Abstract]   [Full Text] [Related]  

  • 6. A systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variability.
    Rodríguez-Perálvarez M; Luong TV; Andreana L; Meyer T; Dhillon AP; Burroughs AK
    Ann Surg Oncol; 2013 Jan; 20(1):325-39. PubMed ID: 23149850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new laboratory-based algorithm to predict microvascular invasion and survival in patients with hepatocellular carcinoma.
    Zhu Y; Xu D; Zhang Z; Dong J; Zhou Y; Zhang WW; Hong L; Zhu WW
    Int J Surg; 2018 Sep; 57():45-53. PubMed ID: 30075291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictor for histological microvascular invasion of hepatocellular carcinoma: a lesson from 229 consecutive cases of curative liver resection.
    Eguchi S; Takatsuki M; Hidaka M; Soyama A; Tomonaga T; Muraoka I; Kanematsu T
    World J Surg; 2010 May; 34(5):1034-8. PubMed ID: 20127241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the extracellular matrix protein periostin in liver tumours and bile duct carcinomas.
    Riener MO; Fritzsche FR; Soll C; Pestalozzi BC; Probst-Hensch N; Clavien PA; Jochum W; Soltermann A; Moch H; Kristiansen G
    Histopathology; 2010 Apr; 56(5):600-6. PubMed ID: 20459570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A wide-margin liver resection improves long-term outcomes for patients with HBV-related hepatocellular carcinoma with microvascular invasion.
    Yang P; Si A; Yang J; Cheng Z; Wang K; Li J; Xia Y; Zhang B; Pawlik TM; Lau WY; Shen F
    Surgery; 2019 Apr; 165(4):721-730. PubMed ID: 30554724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognoses, outcomes, and clinicopathological characteristics of very elderly patients with hepatocellular carcinoma who underwent hepatectomy.
    Shimada S; Kamiyama T; Orimo T; Nagatsu A; Asahi Y; Sakamoto Y; Kamachi H; Taketomi A
    World J Surg Oncol; 2020 Jun; 18(1):122. PubMed ID: 32522259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ASO Author Reflections: Preoperative Hypercoagulability Predicts Poor Prognosis in Hepatocellular Carcinoma Patients with Microvascular Invasion After Hepatectomy.
    Zhang XP; Cheng SQ
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):806-807. PubMed ID: 31654157
    [No Abstract]   [Full Text] [Related]  

  • 13. The Overexpression of CCAR1 in Hepatocellular Carcinoma Associates with Poor Prognosis.
    Ha SY; Kim JH; Yang JW; Kim J; Kim B; Park CK
    Cancer Res Treat; 2016 Jul; 48(3):1065-73. PubMed ID: 26511806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of a novel risk classification of microvascular invasion in patients with hepatocellular carcinoma after resection.
    Zhao H; Chen C; Fu X; Yan X; Jia W; Mao L; Jin H; Qiu Y
    Oncotarget; 2017 Jan; 8(3):5474-5486. PubMed ID: 27729623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-level expression of periostin is closely related to metastatic potential and poor prognosis of hepatocellular carcinoma.
    Lv Y; Wang W; Jia WD; Sun QK; Li JS; Ma JL; Liu WB; Zhou HC; Ge YS; Yu JH; Xia HH; Xu GL
    Med Oncol; 2013 Mar; 30(1):385. PubMed ID: 23275141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of microvascular invasion in tumor stage for hepatocellular carcinoma.
    Park YK; Song SK; Kim BW; Park SK; Chung CW; Wang HJ
    World J Surg Oncol; 2017 Dec; 15(1):225. PubMed ID: 29258507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
    Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
    World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of HOXA13 as a potential marker for diagnosis and poor prognosis of hepatocellular carcinoma.
    Pan TT; Jia WD; Yao QY; Sun QK; Ren WH; Huang M; Ma J; Li JS; Ma JL; Yu JH; Ge YS; Liu WB; Zhang CH; Xu GL
    Tohoku J Exp Med; 2014 Nov; 234(3):209-19. PubMed ID: 25341685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microvascular invasion (MVI) is a poorer prognostic predictor for small hepatocellular carcinoma.
    Du M; Chen L; Zhao J; Tian F; Zeng H; Tan Y; Sun H; Zhou J; Ji Y
    BMC Cancer; 2014 Jan; 14():38. PubMed ID: 24460749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periostin, a matrix protein, has potential as a novel serodiagnostic marker for cholangiocarcinoma.
    Fujimoto K; Kawaguchi T; Nakashima O; Ono J; Ohta S; Kawaguchi A; Tonan T; Ohshima K; Yano H; Hayabuchi N; Izuhara K; Sata M
    Oncol Rep; 2011 May; 25(5):1211-6. PubMed ID: 21347516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.